Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) EBT (2016 - 2025)

CV Sciences (CVSI) has disclosed EBT for 14 consecutive years, with $378000.0 as the latest value for Q4 2025.

  • Quarterly EBT rose 178.91% to $378000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$367000.0 through Dec 2025, up 82.86% year-over-year, with the annual reading at -$367000.0 for FY2025, 82.86% up from the prior year.
  • EBT hit $378000.0 in Q4 2025 for CV Sciences, up from -$382000.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $5.7 million in Q1 2023 to a low of -$9.0 million in Q4 2021.
  • Historically, EBT has averaged -$1.1 million across 5 years, with a median of -$603000.0 in 2024.
  • Biggest five-year swings in EBT: tumbled 2477.5% in 2022 and later surged 476.63% in 2023.
  • Year by year, EBT stood at -$9.0 million in 2021, then surged by 73.62% to -$2.4 million in 2022, then skyrocketed by 62.83% to -$878000.0 in 2023, then soared by 45.44% to -$479000.0 in 2024, then soared by 178.91% to $378000.0 in 2025.
  • Business Quant data shows EBT for CVSI at $378000.0 in Q4 2025, -$382000.0 in Q3 2025, and -$261000.0 in Q2 2025.